Section 905 of FDAAA calls for the
Health and Human Services Secretary to develop methods to obtain
access to disparate data sources and to establish a postmarket risk
identification and analysis system to link and analyze healthcare
data from multiple sources. The law sets a goal of access to data
from 25 million patients by July 1, 2010, and 100 million patients
by July 1, 2012. The law also requires FDA to work closely with
partners from public, academic, and private entities.
This is a one time collection
of information as a result of FDAAA, which mandates FDA to
establish an active surveillance system for monitoring drugs, using
electronic data from healthcare information holders. The Sentinel
Initiative is the FDA's response to that mandate. Its goal is to
build and implement a new active surveillance system that will
eventually be used to monitor all FDA-regulated products.
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.